Predict your next investment

Rubix LS company logo
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Research, Engineering & Technical

See what CB Insights has to offer

Founded Year



Seed | Alive

Total Raised


Last Raised

$1.25M | 10 mos ago

About Rubix LS

Rubix LS is a digital health research and development company focusing on the growing disparity of minority health outcomes. By designing real-world evidence studies within the infectious and rare disease areas, the company is targeting mobile and digital clinical trial options for increasing engagement for minority and underrepresented populations to address wide health outcomes.

Rubix LS Headquarter Location

60 Island St Suite 236

Lawrence, Massachusetts, 01840,

United States


Latest Rubix LS News

Rubix LS Secures $1.25 Million Seed Financing Round

Feb 10, 2021

Rubix LS Secures $1.25 Million Seed Financing Round Culturally-Centric Life Science Company aggressively accelerates the development of the lead platform StarSense and expand the development of a Rubix LS owned clinical trial site for launching clinical trials. LAWRENCE, Mass., February 9, 2021-- Rubix LS, a minority-led life science research firm focusing on solutions to support minorities within clinical trials, announced today that it had completed a $1.25 million Seed round of financing. With the financing round being secured by many private and angel investors, the investment capitalizes on the further momentum for the virtual clinical trial platform, StarSense, and the intimate engagement with minority patients for continued care for early-stage research. Harmonizing on the events during the COVID-19 pandemic, StarSense made further advances globally to support underrepresented groups to be included in infectious disease clinical trial research programs. Furthering from inclusion, the platform has led to a 38% increase in therapeutic benefits for therapies that were otherwise unknown to support and treat specific conditions. "We're ensuring that we don't let the pandemic and any further instances of innovation disregard the underrepresented communities from accessing therapies for conditions and start building trust among the communities at large." - Reginald Swift, Founder & CEO of Rubix LS The Seed financing builds on an exceptional year for Rubix LS which saw a rapidly growing roster of clients, expansion of its internal team, and key market momentum in the white-hot areas of health inequities towards the underrepresented patient populations that has stemmed from the race for a vaccine for COVID-19. About Rubix LS Rubix LS, founded in 2016, is a culturally-centric life science research firm that is building data, products, processes, and programs to wholly support the clinical research continuum that includes minority data sets in every phase of the life science development ecosystem. Enabling its the use of virtual clinical trials, it is bridging the scientific and operational expertise to design custom made solutions that enhance minority patient attention, recruitment, engagement, support, and education so that the life science industry can make better products for everyone. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Rubix LS

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Rubix LS is included in 2 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

317 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Digital Health

11,292 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Rubix LS Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Rubix LS Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.